trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

A small change in weight can lower the risk of developing certain diseases.

the verdict
SUPPORTED
the evidence backs this
Recorded sources
3 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that a small change in weight can lower the risk of developing certain diseases?

Yes. Weight reduction interventions, even of modest degree, are strongly supported by recent clinical data to lower the risk of developing cardiometabolic diseases.

Verdict: SUPPORTED · 3 sources for, 0 against · Last checked

The analysis

The retrieved literature consistently supports the assertion that modest or significant weight changes and associated metabolic interventions reduce disease risks, particularly regarding cardiovascular events and type 2 diabetes.

Evidence for · 3
Understanding Obesity as a Multisystem Disease: Advancing Research, Redefining Diagnostic Criteria, and Establishing Modern Therapeutic Approaches.
2026
Get citation
H, A., M, K., L, M., G, P., MF, F., G, G., & P, P. (2026). Understanding Obesity as a Multisystem Disease: Advancing Research, Redefining Diagnostic Criteria, and Establishing Modern Therapeutic Approaches.. doi.org. https://doi.org/10.3390/nu18142317

See more details
More for · 2
The Role of SGLT2 Inhibitors in the Prevention of Type 2 Diabetes: A Narrative Review of Current Evidence.
2026
Get citation
AC, O., M, B., & L, C. (2026). The Role of SGLT2 Inhibitors in the Prevention of Type 2 Diabetes: A Narrative Review of Current Evidence.. doi.org. https://doi.org/10.1007/s13300-026-01913-0

Effects of GLP-1 receptor agonists on body weight and cardiovascular outcomes: a review.
2026
Get citation
SJF, v. M., EPM, v. D., MM, S., CJJ, T., EFC, v. R., & S, E. M. (2026). Effects of GLP-1 receptor agonists on body weight and cardiovascular outcomes: a review.. doi.org. https://doi.org/10.1007/s12471-026-02073-3

What does the evidence say?

The retrieved literature consistently supports the assertion that modest or significant weight changes and associated metabolic interventions reduce disease risks, particularly regarding cardiovascular events and type 2 diabetes.

Receipt History
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work